1. Home
  2. TEX vs BLTE Comparison

TEX vs BLTE Comparison

Compare TEX & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$64.45

Market Cap

7.6B

Sector

Industrials

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$175.18

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
BLTE
Founded
1933
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.5B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
TEX
BLTE
Price
$64.45
$175.18
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
$68.80
$198.00
AVG Volume (30 Days)
1.1M
148.5K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
N/A
EPS
3.33
N/A
Revenue
$5,421,000,000.00
N/A
Revenue This Year
$47.68
N/A
Revenue Next Year
$6.81
$492.11
P/E Ratio
$19.02
N/A
Revenue Growth
5.73
N/A
52 Week Low
$33.13
$53.60
52 Week High
$71.50
$200.00

Technical Indicators

Market Signals
Indicator
TEX
BLTE
Relative Strength Index (RSI) 57.74 56.90
Support Level $58.60 $167.80
Resistance Level $70.58 $196.14
Average True Range (ATR) 2.33 8.50
MACD 0.79 2.26
Stochastic Oscillator 93.53 77.37

Price Performance

Historical Comparison
TEX
BLTE

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: